Tag : renal cell carcinoma

Healthcare Quality, Patient Safety & Policy

Innovent & HUTCHMED NDA Accepted for Sintilimab Combo in China

PR Newswire
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...